Morning Blend

Actions

Biohaven Pharmaceuticals | 10/24/22

Discussing Obsessive Compulsive Disorder
Posted
and last updated

OCD Advocate Ethan Smith and Dr. John Sonnenberg sat down to discuss obsessive-compulsive disorder and an investigational drug that will treat symptoms. This drug is being made by Biohaven Pharmaceuticals.

This segment is paid for by Biohaven Pharmaceuticals.

Sign up for our Morning E-mail Newsletter to receive the latest headlines in your inbox.